LESCARDEN INC
10QSB/A, 1996-04-09
PHARMACEUTICAL PREPARATIONS
Previous: WESTERN RESOURCES INC /KS, DEFA14A, 1996-04-09
Next: MANNING & NAPIER ADVISORS INC, SC 13G/A, 1996-04-09



              U.S. Securities and Exchange Commission
                      Washington, D.C. 20549

            Form 10-QSB - Quarterly or Transitional Report
            (Added by 34-30968, eff. 8/13/93, as amended)

(Mark One)
[X] Quarterly Report Under Section 13 or 15 (d) of the Securities
Exchange Act of 1934

For the quarterly period ended November 30, 1995.

[   ] Transition Report Under Section 13 or 15(d) of the Securities
Exchange Act of 1934

For the transition period from ____________to_____________

Commission file number 0-10035

                               LESCARDEN, INC.
         (Exact name of small business issuer as specified in its charter)

        New York                                             13-2538207
(State or other jurisdiction of                           (I.R.S. Employer
 incorporation or organization)                           Identification No.)

420 Lexington Avenue, New York Suite 2025                      10170
(Address of principle executive offices)                     (Zip Code)

Issuer's telephone number (212) 687-1050

     __________________________________________________________________.
        (Former name, former address and former fiscal year, if changed         
                                since last report)

     Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. 
Yes [X]   No [ ]

State the number of shares outstanding of each of the issuer's classes of
common equity, as of the latest practicable date.

          Class                               Outstanding at November 30, 1995
Common Stock $.001 par value                                 11,822,010

<PAGE>

                               LESCARDEN INC.

                        Part II - Other Information

Item 6.  Exhibits and Reports on Form 8-K

   (b) Reports on Form 8-K: There were no reports on Form 8-K filed for the
       three months ended November 30, 1995.


<PAGE>
                               SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                       LESCARDEN INC.
                                       (Registrant)


Date:  January 5, 1996                 s/Gerard A. Dupuis
                                       Gerard A. Dupuis
                                       Chairman of the Board
                                       Chief Executive Officer



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM LESCARDEN
INC'S NOVEMBERS 30, 1995 FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAY-31-1996
<PERIOD-END>                               NOV-30-1995
<CASH>                                         105,514
<SECURITIES>                                         0
<RECEIVABLES>                                  148,705
<ALLOWANCES>                                         0
<INVENTORY>                                     13,881
<CURRENT-ASSETS>                               275,600
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 278,680
<CURRENT-LIABILITIES>                        1,302,481
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         1,840
<OTHER-SE>                                 (1,788,641)
<TOTAL-LIABILITY-AND-EQUITY>                   278,680
<SALES>                                        418,021
<TOTAL-REVENUES>                               418,021
<CGS>                                          132,696
<TOTAL-COSTS>                                  132,696
<OTHER-EXPENSES>                               231,963
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 53,362
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             53,362
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    53,362
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission